dr. richard finn on pd 0332991 plus letrozole in er-positive breast cancer
Published 11 years ago • 1K plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:34
dr. richard finn on the future of palbociclib in breast cancer
-
4:43
richard s. finn, md: the combination of pd 0332991 and letrozole phase ii results
-
1:35
dr. richard finn on the rationale for targeting cdk4/6 with pd 0332991
-
1:41
dr. richard finn describes the phase iii trial of palbociclib for breast cancer
-
2:04
dr. richard finn discusses palbociclib for patients with advanced breast cancer
-
1:06
dr. finn on the potential of cdk inhibition
-
1:29
dr. finn on the phase iii paloma-2 trial in er breast cancer
-
1:55
dr. finn on treating er breast cancer patients with antiestrogens
-
1:21
dr. richard finn on what’s next for palbociclib after paloma in breast cancer
-
1:05
dr. finn on amg900 in breast cancer
-
1:20
dr. finn on new cdk 4/6 inhibitors for breast cancer
-
1:53
dr. finn on the inhibition of cdk 4/6 in breast cancer
-
3:03
integrating palbociclib into the treatment of breast cancer
-
2:01
dr. finn on the revolution of cdk4/6 inhibition in hr breast cancer
-
1:50
dr. finn on the future of palbociclib for the treatment of breast cancer
-
6:33
ucla's dr. richard finn discusses new treatment for aggressive breast cancer
-
2:01
dr. finn discusses research in triple-negative breast cancer
-
2:20
dr. finn on current research in triple-negative breast cancer
-
1:05
dr. blok on results of adjuvant letrozole study in breast cancer